Literature DB >> 2303647

Problems in defining normal limits for serum IgE.

M Klink1, M G Cline, M Halonen, B Burrows.   

Abstract

Recommended "normal limits" for serum IgE generally assume that a single upper limit of normal can be applied to all adults. The present article describes the distribution of IgE levels in 2657 subjects in a general population sample in Tucson, Ariz. Limits of IgE defining the lower 5%, 10%, 25%, 50%, 75%, 90%, and 95% in 1569 subjects with negative allergy skin tests and without current asthma, considered a reference group, are provided by age and sex. These cutoffs are then used to compare groups with asthma and with positive allergy skin tests with the reference population. Distributions of IgE levels in these groups are vastly different, but defining an upper "limit of normal" for serum IgE is of doubtful clinical value because there is no single level of IgE that distinguishes different groups with any precision. The spread of IgE values is extremely wide in subjects with and without known allergic diseases.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2303647     DOI: 10.1016/0091-6749(90)90153-u

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  10 in total

1.  The Po River Delta epidemiological survey: reference values of total serum IgE levels in a normal population sample of North Italy (8-78 yrs).

Authors:  M Simoni; P Biavati; S Baldacci; L Carrozzi; M Pedreschi; F Di Pede; T Sapigni; G Viegi
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

2.  High IgE in rheumatoid arthritis (RA) patients is complexed with anti-IgE autoantibodies.

Authors:  N Millauer; A W Zuercher; S M Miescher; H A Gerber; M Seitz; B M Stadler
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

3.  Epigenome-wide association study reveals methylation pathways associated with childhood allergic sensitization.

Authors:  Cheng Peng; Evelien R Van Meel; Andres Cardenas; Sheryl L Rifas-Shiman; Abhijeet R Sonawane; Kimberly R Glass; Diane R Gold; Thomas A Platts-Mills; Xihong Lin; Emily Oken; Marie-France Hivert; Andrea A Baccarelli; Nicolette W De Jong; Janine F Felix; Vincent W Jaddoe; Liesbeth Duijts; Augusto A Litonjua; Dawn L DeMeo
Journal:  Epigenetics       Date:  2019-03-28       Impact factor: 4.528

4.  Prevalence and clinical characteristics of allergic rhinitis in the elderly Korean population.

Authors:  Jae-Sung Nam; Chi-Sang Hwang; Min-Pyo Hong; Kyung-Su Kim
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-08-02       Impact factor: 2.503

Review 5.  Cellular and immunological markers of allergic and intrinsic bronchial asthma.

Authors:  J C Virchow; C Kroegel; C Walker; H Matthys
Journal:  Lung       Date:  1994       Impact factor: 2.584

6.  Antrochoanal polyps and allergy-A comparative study.

Authors:  M Panduranga Kamath; Mahesh Chandra Hegde; Suja Sreedharan; K Padmanabhan
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2002-01

7.  Trajectories of childhood immune development and respiratory health relevant to asthma and allergy.

Authors:  Howard Hf Tang; Shu Mei Teo; Danielle Cm Belgrave; Michael D Evans; Daniel J Jackson; Marta Brozynska; Merci Mh Kusel; Sebastian L Johnston; James E Gern; Robert F Lemanske; Angela Simpson; Adnan Custovic; Peter D Sly; Patrick G Holt; Kathryn E Holt; Michael Inouye
Journal:  Elife       Date:  2018-10-15       Impact factor: 8.140

8.  Markers of atopic dermatitis, allergic rhinitis and bronchial asthma in pediatric patients: correlation with filaggrin, eosinophil major basic protein and immunoglobulin E.

Authors:  Zafar Rasheed; Khaled Zedan; Ghada Bin Saif; Ragaa H Salama; Tarek Salem; Ahmed A Ahmed; Alaa Abd El-Moniem; Maha Elkholy; Ahmad A Al Robaee; Abdullateef A Alzolibani
Journal:  Clin Mol Allergy       Date:  2018-11-12

Review 9.  A Review of Respiratory Biologic Agents in Severe Asthma.

Authors:  Nathaniel Johnson; Blessy Varughese; Marianne A De La Torre; Salim R Surani; George Udeani
Journal:  Cureus       Date:  2019-09-18

10.  Molecular analysis of activation-induced cytidine deaminase gene in immunoglobulin-E deficient patients.

Authors:  Sergio Roa; Maria Isidoro-Garcia; Ignacio Davila; Elena Laffond; Felix Lorente; Rogelio Gonzalez-Sarmiento
Journal:  Clin Dev Immunol       Date:  2009-02-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.